Cara Therapeutics, Inc. (0HTC.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 6.17M |
| Enterprise Value | 12.72M |
| P/E Ratio | -1.53 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.58 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.21 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.6 |
| Return On Equity | -0.64 |
| Revenue | 7.14M |
| Revenue/Share | 0 |
| Gross Profit | 6.33M |
| EBITDA | -62.6M |
| Net Income | -70.87M |
| Diluted EPS | -46.59 |
| Total Cash | 40.99M |
| Total Cash/Share | 2.66 |
| Total Debt | 254,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 2.25 |
| Book Value Per Share | 1.55 |
| 52-Week Change | 359.48 |
| 52-Week High | 15.99 |
| 52-Week Low | 0.5 |
| Moving Average 50 Days | 0.69 |
| Moving Average 200 Days | 1.89 |
| Average Volume | 18,632 |
| Shares Outstanding | 1.52M |
| % Held by Institutions | 0 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 83333:1000000 |
| Last Split Date | December 31, 2024 |